PTU - Polskie Towarzystwo Urologiczne
list of articles:

Renal angiomyolipoma in Bourneville-Pringle syndrome
Article published in Urologia Polska 2005/58/1.


Bartosz Małkiewicz, Janusz Dembowski, Michał Wróbel, Romuald Zdrojowy, Anna Kołodziej, Jerzy Lorenz
Katedra i Klinika Urologii i Onkologii Urologicznej Akademii Medycznej we Wrocławiu
Kierownik kliniki: prof. dr hab. Jerzy Lorenz


kidney, angiomyolipoma, Bourneville-Pringle syndrom


Bourneville-Pringle syndrome is a rare genetically determined pathologic syndrome, observed at a 1/6000 - 1/14,500 incidence rate. The primary features of clinical presentation include: mental retardation, epilepsy and hard nodules located in the region of cheeks and nasobuccal folds. Ca 80% of patients with Bourneville-Pringle syndrome develop kidney lesions of angiomyolipoma (AML) type.
aim of the study
The paper discusses the Bourneville-Pringle syndrome, its etiology, clinical symptoms, diagnostics and treatment of angiomyolipomas (AML) coincident with TSC.
material and methods
Two cases of female patients with Bourneville-Pringle syndrome (TSC) with giant bilateral multifocal renal angiomyolipomas (AML) filling the whole abdominal cavity are presented. The patients underwent surgical treatment sparing the renal parenchyma. Improvement of the patients' clinical condition and normalization of renal function parameters, obtained during the post-operative period, were also observed in long-term follow-up.
Multifocal character, considerable dynamics of growth, bilateral location, and, first of all, the tendency to reach big sizes typical of AML in patients with ST syndrome necessitates early and close radiological monitoring, and in each case requiring surgical treatment - consideration of surgery sparing the renal parenchyma in order to preserve normal renal function.


  1. Lewis JC, Thomas HV, Murphy KC, Sampson JR: Genotype and psychological phenotype in tuberous sclerosis. J Med Genet 2004; 41 (3); 203-207.
  2. Nelson CP, Sanda MG: Contemporary diagnosis and management of renal angiomyolipoma. J Urol 2002; 168; 1315-1325.
  3. Jones AC, Shyamsundar MM, Thomas MW et al: Comprehensive mutation analysis of TSC1 and TSC2 - and phenotypic correlations in 150 families with tuberous sclerosis. AM J Hum Genet 1999; 64 (5); 1305-1315.
  4. Pastewka K, Borówka A, Pypno W, Jóźwiak S: Rozległy Angiomyolipoma nerki u chorej na stwardnienie guzowate. Urol Pol 2000; 53; 407-414.
  5. Eble JN: Angiomyolipoma of kidney. Semin Diagn Pathol 1998; 15; 21-40.
  6. Neumann HP, Schwarzkopf G, Henske EP: Renal angiomyolipomas, cysts, and cancer in tuberous sclerosis complex. Semin Pediatr Neurol 1998; 5 (4); 269-275.
  7. O´Hagan AR, Ellsworth R, Secic MS et al: Renal manifestations of tuberous sclerosis complex. Clin Pediatr 1996; 183.
  8. Webb DW, Osborne JP, Fryer AE: On the incidence of mental retardation in tuberous sclerosis. J Med Genet 1991; 28; 385.
  9. Klijer R, Bar K, Białek W, Pietura R: Angiofibromyolipoma nerki imitujący guz nadnercza. Urol Pol 2002; 55; 69-71.
  10. Henske EP, Neumann HP, Scheithauer BW, Herbst EW, Short MP, Kwiatkowski DJ: Loss of heterozygosity in the tuberous sclerosis (TSC2) region of chromosome band 16p13 occurs in sporadic as well as TSC-associated renal angiomyolipomas. Genes Chromosomes Cancer 1995; 13 (4); 295-298.
  11. Tee AR, Fingar DC, Manning BD, Kwiatkowski DJ, Cantley LC, Blenis J: Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR) - mediated downstream signaling. Proc Natl Acad Sci USA 2002; 99 (21); 13571-13576.
  12. Steiner MS, Goldman SM, Fishman EK, Marshall FF: The natural history of renal angiomyolipoma. J Urol 1993; 150; 1782-1786.
  13. Oesterling JE, Fishman EK, Goldman SM, Marshall FF: The management of renal angiomyolipoma. J Urol 1986; 135; 1121-1124.
  14. Ciancio SJ, Vira M, Simon MA, Lerner SP, Schulam PG: Giant bilateral renal angiomyolipomas associated with tuberous sclerosis. Urology 2001; 57 (3); 554.
  15. Neumann HP, Bruggen V, Berger DP et al: Tuberous sclerosis complex with end-stage renal failure. Nephrol Dial Transplant 1995; 10; 349-353.
  16. Bernstein J: Glomerolocystic kidney disease nosological considerations. Pediatr Nephrol 1993; 7; 464.
  17. Dickinson M, Ruckle H, Beaghler M, Hadley HR: Renal angiomyolipoma: Optimal treatment based on size and symptoms. Clin Nephrol 1998; 49; 281-286.
  18. Kennelly MJ, Grossman HB, Cho KJ: Outcome analysis of 42 cases or renal angiomyolipoma. J Urol 1994; 152; 1988-1991.
  19. Shiroyanagi Y, Kondo T, Tomita E et al: Nephron-sparing tumorectomy for a large benign renal mass: a case of massive bilateral renal angiomyolipomas associated with tuberous sclerosis. Int J Urol 2002; 9; 117-119.
  20. Hamlin JA, Smith DC, Taylor FC et al: Renal angiomyolipomas: Long-term of embolization of acute hemorrhage. Can Assoc Radiol J 1997; 48; 191-198.
  21. Han YM, Kim JK, Roh BS, et al: Renal angiomyolipoma: Selective arterial embolization-effectiveness and changes in angiomyogenic components in long-term follow-up. Radiology 1997; 204; 65-70.


Bartosz Małkiewicz
Klinika Urologii i Onkologii Urologicznej AM
pl. 1 Maja 8
50-043 Wrocław
tel. (0... 71) 34 34 75